OCULO THERAPY

Oculo Therapy is a biotechnology company based in Memphis, Tennessee.

#People #More

OCULO THERAPY

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2014-01-01

Address:
Memphis, Tennessee, United States

Country:
United States

Status:
Active

Total Funding:
20 K USD


Founder


monica-jablonski_image

Monica Jablonski

More informations about "Oculo Therapy"

OculoTherapy - BIO International Convention | BIO

Jun 5, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. Skip to main content Policy. Get Involved. Join BIOAction. …See details»

About – OculoTherapy

We have built a company dedicated to preserving the ability to see. OculoTherapy was formed from the vision of Dr. Monica Jablonski at the Hamilton Eye Institute, University of Tennessee …See details»

Technology – OculoTherapy

Neuroprotection Glaucoma Therapy. Our second novel formulation, PGM-10, (patent pending), offers protection against damage to retinal ganglion cells (RGCs) and their axons that comprise the optic nerve, thus shielding against …See details»

UTHSC Startup OculoTherapy Develops Novel …

Jul 23, 2018 An innovative once-daily topical medicine promises to overcome the challenges associated with current glaucoma treatments by improving drug delivery. Developed by Monica M. Jablonski, Ph.D., Professor in the …See details»

Oculo Therapy - Crunchbase Company Profile & Funding

Oculo Therapy is a biotechnology company based in Memphis, Tennessee. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. ...See details»

Our Leadership – OculoTherapy

Having earned his PhD in Genetics, Genomics, and Informatics from the University of Tennessee Health Science Center and gained experience in computer technologies and network security over the past five years, Dr. …See details»

OculoTherapy - LinkedIn

We have built a company dedicated to preserving the ability to see. OculoTherapy was founded by Dr. Monica Jablonski at the Hamilton Eye Institute, University of Tennessee Health Science Center ...See details»

Oculo Therapy, LLC - VentureRadar

Oculo Therapy, LLC Follow Following Location: USA. Founded in 2014. Privately Held. Develops a once-daily topical medicine for glaucoma treatment, improving drug delivery, founded by …See details»

OculoTherapy, a founded by Monica Jablonski, is …

Nov 30, 2021 These two latter grants have also received partial matching funds — worth $135,000 and $100,000, respectively — from entrepreneurial support organization LaunchTN.See details»

The Canadian Society of Ocularists

Learn more about the professional not-for-profit organization representing Ocularists in Canada. Who we are The role of the Canadian Society of Ocularists is to inform the public, health professionals and government about custom …See details»

Oculo Therapy - Crunchbase

Oculo Therapy is a biotechnology company based in Memphis, Tennessee.See details»

Oculo Therapy - Funding, Financials, Valuation & Investors

Oculo Therapy is a biotechnology company based in Memphis, Tennessee. How much funding has this organization raised over time? ShowSee details»

OculoTherapy - Products, Competitors, Financials, Employees ...

About OculoTherapy. OculoTherapy is a biotechnology company focused on developing innovative treatments for eye diseases. The company specializes in creating targeted …See details»

Investors – OculoTherapy

1) Global Data Market Research Report, “Glaucoma Competitive Landscape to 2016-2026”, (January 2019) available by subscription.See details»

Oculomotor Treatment in Traumatic Brain Injury Rehabilitation: A ...

Oct 25, 2019 Visual impairments are common after traumatic brain injury (TBI). Studies estimate that as many as 90% of people with TBI experience injury-related vision impairments …See details»

Oculomotor Movements as the Foundation of Visually Processing …

May 10, 2023 – Linda Gerra, American Occupational Therapy Association Annual Conference 2016. Eighty percent of all learning occurs visually. Visual dysfunction occurs in 50-70% of all …See details»

Gene Therapy for Ocular Disease - QPS

Nov 8, 2023 Ocular Gene Therapy Approaches. Thanks to its small size, ease of access, and immune-privileged state, the eye is a promising target for gene therapy. However, given the …See details»

Oculo Plastics - Misericordia Health Centre

Oculoplastics Procedures Français / English Oculoplastics is a subspecialty of ophthalmology which deals with the eyelid, tear duct system and orbital conditions including infections, trauma …See details»

Oculomotor Treatment in Traumatic Brain Injury Rehabilitation: A ...

Oct 25, 2019 Abstract. Importance: Vision impairments are common after traumatic brain injury (TBI). Little evidence exists to assist clinicians with effective interventions for impaired …See details»

Oculomotor Treatment in Traumatic Brain Injury Rehabilitation: A ...

Oculomotor dysfunction seems to improve during inpatient TBI rehabilitation with remedial treatment. Best practice in occupational therapy has not yet been established. An …See details»